POST-MARKETING SURVEILLANCE - HOW MANY PATIENTS

被引：55

作者：

LEWIS, JA

机构：

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1981年 / 2卷 / 04期

关键词：

D O I：

10.1016/0165-6147(81)90275-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：93 / 94

页数：2

相关论文

共 5 条

[1] MONITORING ADVERSE REACTIONS TO DRUGS
DOLLERY, CT
RAWLINS, MD
[J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6053) : 96 - 97
[2] SYSTEMATIC SIGNALING OF ADVERSE REACTIONS TO DRUGS
FINNEY, DJ
[J]. METHODS OF INFORMATION IN MEDICINE, 1974, 13 (01) : 1 - 10
[3] SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY
HALPERIN, M
ROGOT, E
GURIAN, J
EDERER, F
[J]. JOURNAL OF CHRONIC DISEASES, 1968, 21 (01): : 13 - &
[4] CASE FOR RECORDING EVENTS IN CLINICAL-TRIALS
SKEGG, DCG
DOLL, R
[J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6101) : 1523 - 1524
[5] POST-MARKETING SURVEILLANCE OF ADVERSE REACTIONS TO NEW MEDICINES
WILSON, AB
[J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6093) : 1001 - 1003